Pharmaceuticals, Biotechnology and Life Sciences
BEVERLY HILLS, Calif.–(BUSINESS WIRE)–GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company’s…
IQVIA OCE sees rapid growth, including expanded global OCE rollout by a top-10 pharma company DANBURY, Conn. & RESEARCH TRIANGLE…
− Achieved Fourth Quarter and Full Year 2020 Global Net Product Revenues of $113 Million and $362 Million, Respectively –…
BEVERLY HILLS, Calif.–(BUSINESS WIRE)–GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company’s…
– Study Results Highlight Potential Utility of Targeting Mannose 6-Phosphate Pathway to Treat Gaucher Disease and Mucolipidosis II – ST.…
BURLINGAME, Calif.–(BUSINESS WIRE)–Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response…
– Study Results Highlight Potential Utility of Targeting Mannose 6-Phosphate Pathway to Treat Gaucher Disease and Mucolipidosis II – ST.…
– Collaboration leverages Repertoire’s DECODE platform to identify novel antigens for future therapies CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines, a clinical-stage…
– Collaboration leverages Repertoire’s DECODE platform to identify novel antigens for future therapies CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines, a clinical-stage…
– Collaboration leverages Repertoire’s DECODE platform to identify novel antigens for future therapies CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines, a clinical-stage…